Work

Figure S9 from Immunoproteasome Activation Expands the MHC Class I Immunopeptidome, Unmasks Neoantigens, and Enhances T-cell Anti-Myeloma Activity

Year: 2024

Type: other

Abstract: Figure S9. Effect of Btz and Compound A alone and combined in a. RPMI-8226, b. ARH77, c. U266 and d. E.G7-Ova cells. Cell viability was determined using the XTT assay. Assays were performed in triplicate. Staurosporine (ST, 2 uM) represents a positive control for cell death.

DOI: 10.1158/1535-7163.27951033

Authors: Priyanka S. Rana, James J. Ignatz-Hoover, Chunna Guo, Amber L. Mosley, Ehsan Malek, Yuriy Federov, Drew J. Adams, James J. Driscoll

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4404975782

Cites:

Cited by:

Related to: 10